These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25023822)

  • 1. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.
    Dorbala S; Vangala D; Bruyere J; Quarta C; Kruger J; Padera R; Foster C; Hanley M; Di Carli MF; Falk R
    JACC Heart Fail; 2014 Aug; 2(4):358-67. PubMed ID: 25023822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Coronary Flow Velocity Reserve and Decreased Myocardial Contractile Reserve Are Main Factors in Relation to Physical Exercise Capacity in Cardiac Amyloidosis.
    Clemmensen TS; Eiskjær H; Mølgaard H; Larsen AH; Soerensen J; Andersen NF; Tolbod LP; Harms HJ; Poulsen SH
    J Am Soc Echocardiogr; 2018 Jan; 31(1):71-78. PubMed ID: 29111120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease.
    Valenta I; Quercioli A; Schindler TH
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):387-96. PubMed ID: 24631507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-endocardial and sub-epicardial measurement of myocardial blood flow using
    Sciagrà R; Milan E; Giubbini R; Kubik T; Di Dato R; Gallo L; Camoni L; Allocca M; Calabretta R
    J Nucl Cardiol; 2020 Oct; 27(5):1665-1674. PubMed ID: 30238298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study.
    Gulati A; Ismail TF; Ali A; Hsu LY; Gonçalves C; Ismail NA; Krishnathasan K; Davendralingam N; Ferreira P; Halliday BP; Jones DA; Wage R; Newsome S; Gatehouse P; Firmin D; Jabbour A; Assomull RG; Mathur A; Pennell DJ; Arai AE; Prasad SK
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1699-1708. PubMed ID: 30660522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health.
    Schindler TH; Schelbert HR; Quercioli A; Dilsizian V
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):623-40. PubMed ID: 20541718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation.
    Wijesurendra RS; Liu A; Notaristefano F; Ntusi NAB; Karamitsos TD; Bashir Y; Ginks M; Rajappan K; Betts TR; Jerosch-Herold M; Ferreira VM; Neubauer S; Casadei B
    J Am Heart Assoc; 2018 Aug; 7(15):e009218. PubMed ID: 30371239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease.
    Jagathesan R; Kaufmann PA; Rosen SD; Rimoldi OE; Turkeimer F; Foale R; Camici PG
    J Nucl Med; 2005 Feb; 46(2):212-9. PubMed ID: 15695778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction.
    Schindler TH; Facta AD; Prior JO; Campisi R; Inubushi M; Kreissl MC; Zhang XL; Sayre J; Dahlbom M; Schelbert HR
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1140-9. PubMed ID: 16639609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
    Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
    J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function.
    Chen WJ; Danad I; Raijmakers PG; Halbmeijer R; Harms HJ; Lammertsma AA; van Rossum AC; Diamant M; Knaapen P
    Am J Cardiol; 2014 Jan; 113(1):90-7. PubMed ID: 24169015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET.
    El Fakhri G; Kardan A; Sitek A; Dorbala S; Abi-Hatem N; Lahoud Y; Fischman A; Coughlan M; Yasuda T; Di Carli MF
    J Nucl Med; 2009 Jul; 50(7):1062-71. PubMed ID: 19525467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial perfusion in cardiac amyloidosis.
    Chacko L; Kotecha T; Ioannou A; Patel N; Martinez-Naharro A; Razvi Y; Patel R; Massa P; Venneri L; Brown J; Porcari A; Knott K; Manisty C; Knight D; Lockie T; Rakhit R; Lachmann H; Wechelakar A; Whelan C; Ponticos M; Moon J; González A; Gilbertson J; Riefolo M; Leone O; Xue H; Hawkins P; Kellman P; Gillmore J; Fontana M
    Eur J Heart Fail; 2024 Mar; 26(3):598-609. PubMed ID: 38247182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blunting of coronary flow reserve in hypertension with left ventricular hypertrophy is transmural and correlates with systolic blood pressure.
    Rimoldi O; Rosen SD; Camici PG
    J Hypertens; 2014 Dec; 32(12):2465-71; discussion 2471. PubMed ID: 25188369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial flow reserve in long-term survivors of repair of anomalous left coronary artery from pulmonary artery.
    Singh TP; Di Carli MF; Sullivan NM; Leonen MF; Morrow WR
    J Am Coll Cardiol; 1998 Feb; 31(2):437-43. PubMed ID: 9462590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity.
    Campisi R; Czernin J; Schöder H; Sayre JW; Marengo FD; Phelps ME; Schelbert HR
    Circulation; 1998 Jul; 98(2):119-25. PubMed ID: 9679717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging.
    Mishra RK; Dorbala S; Logsetty G; Hassan A; Heinonen T; Schelbert HR; Di Carli MF;
    J Am Coll Cardiol; 2005 Feb; 45(4):553-8. PubMed ID: 15708703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
    Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Outflow Tract Contributions to 82Rb-PET Global Myocardial Blood Flow Computations.
    Van Tosh A; Reichek N; Palestro CJ; Nichols KJ
    J Nucl Med Technol; 2016 Jun; 44(2):78-84. PubMed ID: 26966126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.